Pharmaceuticals
Actavis in talks to buy Forest Laboratories for around $25 bn
18 Feb 2014
Actavis, the world's third-largest generics prescription drug manufacturer, hopes to use the Forest acquisition to deal with the tying up of hospitals, insurers and doctors to negotiate directly to buy prescription drugs at cheaper rates from manufacturers
Appeals by Indian drug firms fail to impress FDA’s Hamburg
By By Jagdeep Worah | 17 Feb 2014
India’s pharmaceutical industry supplies 40 per cent of over-the-counter and generic prescription drugs consumed to the United States. Jagdeep Worah reports
US, Indian drug authorities agree on regulatory cooperation
11 Feb 2014
Indian manufacturers supply nearly 40 per cent of the total generic drug needs of the US
Cheaper drugs not necessarily spurious, India tells US FDA
11 Feb 2014
India has drawn the FDA commissioner's attention to the fact that most of the time, audit inspections were not followed by discussions with the companies and harsh decisions were taken before a reply was received
Pharma MNCs seek US action against generic threat from India
06 Feb 2014
US pharma majors have sought President Barack Obama’s intervention to stop generic threat to high-value drug patents amidst a string of new generic drug releases by Indian companies
